Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Vaccine”

388 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 388 results

Post-approval studies (Phase 4)Study completedNCT00290329
What this trial is testing

Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 249
Large-scale testing (Phase 3)Study completedNCT02842853
What this trial is testing

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 3,344
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Testing effectiveness (Phase 2)Study completedNCT01049035
What this trial is testing

A Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 580
Post-approval studies (Phase 4)Study completedNCT01430689
What this trial is testing

Maternal Flu Vaccine Trial in Bamako, Mali

Who this might be right for
Influenza
University of Maryland, Baltimore 4,193
Testing effectiveness (Phase 2)Study completedNCT00135564
What this trial is testing

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT02640404
What this trial is testing

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 224
Testing effectiveness (Phase 2)Study completedNCT00196963
What this trial is testing

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 125
Large-scale testing (Phase 3)Study completedNCT03537508
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 2,627
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Post-approval studies (Phase 4)Study completedNCT04450498
What this trial is testing

Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Who this might be right for
Neisseria Meningitides Meningitis
Walvax Biotechnology Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT00471081
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 385
Large-scale testing (Phase 3)Study completedNCT02986854
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 704
Testing effectiveness (Phase 2)Study completedNCT00560313
What this trial is testing

Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults

Who this might be right for
Meningococcal Disease
Novartis Vaccines 54
Large-scale testing (Phase 3)Study completedNCT00496015
What this trial is testing

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 750
Early research (Phase 1)Study completedNCT00678652
What this trial is testing

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine

Who this might be right for
Meningococcal Infection, Group B
U.S. Army Medical Research and Development Command 36
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Large-scale testing (Phase 3)Study completedNCT03547271
What this trial is testing

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Who this might be right for
Meningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,660
Post-approval studies (Phase 4)Study completedNCT02569632
What this trial is testing

Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)

Who this might be right for
Meningococcal Infections
UCSF Benioff Children's Hospital Oakland 18
Load More Results